The clinical characteristics and mortal causes analysis of COVID-19 death patients
Ao-Xiang Guo, View ORCID ProfileJia-Jia Cui, Qian-Ying OuYang, Li He, View ORCID ProfileCheng-Xian Guo, Ji-Ye Yin
doi: https://doi.org/10.1101/2020.04.12.20062380
Ao-Xiang Guo
1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078; P. R. China; Institute of Clinical Pharmacology, Central South University; Hunan Key Laboratory of Pharmacogenetics, Changsha 410078; P. R. China
2Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, P. R. China
3National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, P.R. China
Jia-Jia Cui
1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078; P. R. China; Institute of Clinical Pharmacology, Central South University; Hunan Key Laboratory of Pharmacogenetics, Changsha 410078; P. R. China
2Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, P. R. China
3National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, P.R. China
Qian-Ying OuYang
1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078; P. R. China; Institute of Clinical Pharmacology, Central South University; Hunan Key Laboratory of Pharmacogenetics, Changsha 410078; P. R. China
2Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, P. R. China
3National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, P.R. China
Li He
5Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, Changsha, 410013, Hunan, P.R. China
Cheng-Xian Guo
6Center of Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, PR China
Ji-Ye Yin
1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078; P. R. China; Institute of Clinical Pharmacology, Central South University; Hunan Key Laboratory of Pharmacogenetics, Changsha 410078; P. R. China
2Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, P. R. China
3National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan, P.R. China
4Hunan Key Laboratory of Precise Diagnosis and Treatment of Gastrointestinal Tumor, Changsha 410078, P. R. China
Data Availability
The data of all anonymous dead patients infected with COVID-19 was publicized by local health authorities in China.
Posted April 15, 2020.
The clinical characteristics and mortal causes analysis of COVID-19 death patients
Ao-Xiang Guo, Jia-Jia Cui, Qian-Ying OuYang, Li He, Cheng-Xian Guo, Ji-Ye Yin
medRxiv 2020.04.12.20062380; doi: https://doi.org/10.1101/2020.04.12.20062380
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2766)
- Dermatology (236)
- Emergency Medicine (415)
- Epidemiology (12420)
- Forensic Medicine (10)
- Gastroenterology (785)
- Genetic and Genomic Medicine (4284)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2765)
- Health Policy (1024)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4061)
- Nursing (218)
- Nutrition (602)
- Oncology (2143)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6665)
- Radiology and Imaging (1455)
- Respiratory Medicine (887)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (466)
- Toxicology (57)
- Transplantation (194)
- Urology (171)